EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of BRCA1 Gene Expression and CA15‐3 Tumor Marker Level in Different Stages of Breast Cancer

Negar Soltani Irdmusa iD, Haniyeh Bashi Zadeh Fakhar iD, Masoumeh Heshmati, Mohammad Esmaiel Akbari iD, Sara Rahimi

The Breast Journal · 2024

DOI: 10.1155/2024/3461694 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift The Breast Journal, 2024. Verfasst von Negar Soltani Irdmusa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Sciences Faculty of Advanced Sciences and Technology Tehran Medical Science Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, BRCA1 Protein, Mucin-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Islamic Azad University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC), a globally prevalent malignancy, shows significant variability in incidence across different geographical regions. In this study, we examined the expression of the tumor suppressor gene BRCA1 and the tumor marker CA15‐3 in women diagnosed with BC, focusing on different cancer grades. Our research, conducted at the Baqiyat Elah Hospital in Tehran in 2021, involved collecting blood and serum samples from BC patients. These samples underwent BRCA1 gene expression analysis and CA15‐3 tumor marker assessment. Using the AJCC grading system, we categorized BC patients into various grades. Our findings revealed that BRCA1 gene expression was present in 28.57% of patients, while 71.43% showed negative expression. Both BRCA1 expression and CA15‐3 levels significantly increased with advanced cancer stages ( P < 0.001). These results suggest the potential utility of BRCA1 gene expression and CA15‐3 tumor marker assessment in BC prognosis and management, particularly concerning staging and disease progression. This study provides valuable insights into the biology of BC and the development of prognostic markers for improved patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorBRCA1 ProteinMucin-1HumansFemaleMiddle AgedAdultNeoplasm StagingAged

Substanzen

Biomarkers, TumorBRCA1 ProteinBRCA1 protein, humanMucin-1MUC1 protein, human

Autor:innen und Institutionen

  • Department of Cell and Molecular Sciences Faculty of Advanced Sciences and Technology Tehran Medical Science Islamic Azad University, Tehran, Iran.
  • Department of Laboratory Science Chalus Branch Islamic Azad University, Chalus, Iran.
  • Cancer Research Center Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Negar Soltani Irdmusa, Haniyeh Bashi Zadeh Fakhar, Mohammad Esmaiel Akbari

Förderung

  • Islamic Azad University

Zitieren

APA

Soltani Irdmusa, N., Bashi Zadeh Fakhar, H., Heshmati, M., Akbari, M. E., & Rahimi, S. (2024). Comparison of BRCA1 Gene Expression and CA15‐3 Tumor Marker Level in Different Stages of Breast Cancer. The Breast Journal. https://doi.org/10.1155/2024/3461694

Vancouver

Soltani Irdmusa N, Bashi Zadeh Fakhar H, Heshmati M, Akbari ME, Rahimi S. Comparison of BRCA1 Gene Expression and CA15‐3 Tumor Marker Level in Different Stages of Breast Cancer. The Breast Journal. 2024. doi:10.1155/2024/3461694

BibTeX
@article{SoltaniIrdmusa2024,
  author = {Soltani Irdmusa, Negar and Bashi Zadeh Fakhar, Haniyeh and Heshmati, Masoumeh and Akbari, Mohammad Esmaiel and Rahimi, Sara},
  title = {Comparison of BRCA1 Gene Expression and CA15‐3 Tumor Marker Level in Different Stages of Breast Cancer},
  journal = {The Breast Journal},
  year = {2024},
  doi = {10.1155/2024/3461694}
}
Kostenlos starten →